5 days ago · AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmaker's $50 billion investment plan in the company's largest …

5 days ago · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities.JPM26: …

Aug 1, 2022 · Anonymous board for AstraZeneca. We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces. …

Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales

Feb 23, 2025 · Anonymous board for Pfizer. We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces. We’re …

Jul 24, 2025 · AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis to pay …

Jul 19, 2015 · Anonymous discussion boards for pharmaceutical and biotech companies

Nov 5, 2025 · AstraZeneca announced Monday that it has secured FDA approval for an add-on to its blockbuster rare disease franchise, providing a potential differentiator as it tries to hold off …

Dec 4, 2025 · In return for the exclusive rights, AstraZeneca’s Alexion Pharmaceuticals rare disease unit is liable to pay up to $780 million in a combination of upfront and potential development, regulatory …

Source Clinical Trials Arena Headline ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC News Tags ASCO 2023 AstraZeneca clinical trials non-small cell lung …